# Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity

> **NCT03096288** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 259 (actual)

## Conditions studied

- Atherosclerotic Cardiovascular Disease

## Interventions

- **DRUG:** Evolocumab
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03096288
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-03
- **Primary completion:** 2020-11-02
- **Final completion:** 2020-11-02
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2022-02-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03096288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03096288, "Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03096288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*